Physician profile
Kate E Hesser
NPI 1972623312
$442.81
in general payments reported to CMS, 2019-2025
16 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.94 · 2020: $27.20 · 2021: $15.67 · 2022: $19.96 · 2023: $94.58 · 2024: $103 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $101.02 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $44.40 | 2022-2025 | Spravato |
| Boston Scientific Corporation | $41.94 | 2020-2025 | Intracept |
| Pfizer INC. | $38.83 | 2023-2024 | |
| Astellas Pharma US INC | $34.76 | 2025 | Veozah |
| Amgen INC. | $30.43 | 2023-2025 | Evenity, Prolia |
| Sanofi Pasteur INC. | $17.50 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.44 | 2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $16.58 | 2024 | Rexulti |
| Inspire Medical Systems, INC. | $16.55 | 2023 | Inspire |
| Lundbeck LLC | $14.60 | 2024 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $14.20 | 2024 | Farxiga |
| Exact Sciences Corporation | $13.94 | 2023 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $13.93 | 2025 | Camzyos |
| Lilly USA, LLC | $13.75 | 2025 | Zepbound, Mounjaro |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kate Hesser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.